Stoke Therapeutics Inc (NASDAQ:STOK)
| 4.06 BATS BZX Real-Time Price As of 9:47am ET |  +0.12 / +3.05%Today’s Change | 3.35 Today|||52-Week Range 14.00 | -56.01% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Assets | Cash | 1.8M | 105.4M | -- | -- | |
| Short Term Investment Cash | 477.0K | 103.8M | -- | -- | ||
| Cash & Short Term Investments | 1.8M | 105.4M | -- | -- | ||
| Receivables | Receivables | 0.00 | 196.0K | -- | -- | |
| Inventories | Inventories | 0.00 | 0.00 | -- | -- | -- |
| Current Assets | Other Current Assets | 113.0K | 548.0K | -- | -- | |
| Current Assets | 1.9M | 106.1M | -- | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 645.0K | 1.6M | -- | -- | |
| Depreciation | -172.0K | -379.0K | -- | -- | ||
| Other Assets | 0.00 | 0.00 | -- | -- | -- | |
| Total Assets | 2.4M | 107.5M | -- | -- | ||
| Liabilities | Accounts Payable | 141.0K | 1.1M | -- | -- | |
| Short Term Debt | 3.0M | 0.00 | -- | -- | ||
| Accrued Expenses | 192.0K | 495.0K | -- | -- | ||
| Other Current Liabilities | 192.0K | 495.0K | -- | -- | ||
| Other Liabilities | 3.7M | 2.5M | -- | -- | ||
| Total Liabilities | Other Liabilities | 16.0K | 4.0K | -- | -- | |
| Total Liabilities | 3.7M | 2.5M | -- | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | -- | -- | -- |
| Preferred Stock | 5.0K | 23.0K | -- | -- | ||
| Common Equity | -1.3M | 105.0M | -- | -- | ||
| Total Shareholder Equity | -1.3M | 105.1M | -- | -- | ||
| Share Information | Common Shares Outstanding | 31.3M | 31.3M | -- | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
